SCHEMBL19081521

SCHEMBL19081521

c1ccc(-c2c3ccccc3c(-c3cccc(-c4cc5c(oc6ccc7ccccc7c65)c5c4oc4ccccc45)c3)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.41
AHR P35869 3/20 0.41
CYP1A1 P04798 2/20 0.41
CYP1A2 P05177 2/20 0.41
PAX8 Q06710 2/20 0.41
FYN P06241 1/20 0.41
MAPK3 P27361 1/20 0.41
TDP1 Q9NUW8 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 5/20 0.39
TSHR P16473 4/20 0.39
HSD17B10 Q99714 4/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 3/20 0.39
ALDH1A1 P00352 3/20 0.39
ALOX15 P16050 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
KMT2A Q03164 2/20 0.37
MAPK1 P28482 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15783728 0.92 AHR (0.39) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL10122302 0.87 ALOX5 (0.43) ABCG2AHRL3MBTL1KDM4ETSHR
SCHEMBL24571158 0.87 TDP1 (0.39) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL10122311 0.86 ALOX5 (0.41) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL9950744 0.86 ALOX5 (0.39) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL24604467 0.86 CYP1A1 (0.43) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL10122278 0.86 ALOX5 (0.41) AHRTDP1L3MBTL1KDM4ETSHR
SCHEMBL10122310 0.86 ALOX5 (0.41) AHRTDP1L3MBTL1KDM4ETSHR
SCHEMBL19081525 0.85 ABCG2 (0.41) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL10122305 0.85 ALOX5 (0.40) ABCG2AHRCYP1A1CYP1A2PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.